Barclays Discloses Stakes in Tate & Lyle, Prologis, Mobico and Spire Healthcare
Barclays filed Form 8.3 disclosures showing its positions in Tate & Lyle, Prologis, Mobico and Spire Healthcare as of 19 November 2026, via RNS.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Barclays published Form 8.3 disclosures through RNS on 20 November 2026, as required by the UK Takeover Code. The filings cover dealings carried out on 19 November. In Tate & Lyle, the bank's combined long position reached 3.12%, while its short position stood at 3.13%. For Prologis, where the bank also reported positions in SEGRO PLC, the long share was 0.24% and the short share 0.17%.
In Mobico Group, Barclays' total long position came to 7.80% and its short position to 7.81%. In Spire Healthcare Group, the long share was 3.29% and the short share 3.30%. Holders must make such disclosures when their stake in a company involved in a takeover offer reaches 1% or more.
why it matters
Filings of this kind appear regularly and do not by themselves signal new deals. For investors, the more relevant point is that large holders are actively trading these shares during takeover situations, which can affect liquidity and price moves.
tags
instruments
sources
- REG - Barclays PLC Tate & Lyle PLC - Form 8.3 TATE & LYLE PLC — Reuters, 20 November 2026 at 13:21 UTC
- REG - Barclays PLC Prologis, Inc. - Form 8.3 PROLOGIS, INC. — Reuters, 20 November 2026 at 13:20 UTC
- REG - Barclays PLC Mobico Group PLC - Form 8.3 MOBICO GROUP PLC — Reuters, 20 November 2026 at 13:20 UTC
- REG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC — Reuters, 20 November 2026 at 13:20 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗